title: 5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.
abstract: Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycles with only minor toxicity and are in continuous partial response, with stable peripheral blood counts, at 29 and 30 cycles from treatment start.
authors.affiliation: Istituto di Ematologia, Università Cattolica Sacro Cuore, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Greco
authors.forename: M
authors.initials: M
authors.lastname: Criscuolo
authors.forename: L
authors.initials: L
authors.lastname: Fianchi
authors.forename: E
authors.initials: E
authors.lastname: Fabiani
authors.forename: L
authors.initials: L
authors.lastname: Pagano
authors.forename: Mt
authors.initials: M
authors.lastname: Voso